M B Elam
Affiliation: University of Tennessee
- Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudicationM B Elam
Departments of Pharmacology and Medicine, University of Tennessee Health Science Center and Veterans Affairs Medical Center, Memphis, Tennessee, USA
Arterioscler Thromb Vasc Biol 18:1942-7. 1998..001). These results indicate that in addition to improving the symptoms of IC, cilostazol also favorably modifies plasma lipoproteins in patients with peripheral arterial disease. The mechanism of this effect is currently unknown...
- Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)C M Chesney
Departments of Medicine and Pathology, University of Tennessee, Memphis, USA
Am Heart J 140:631-6. 2000..The objective of this study was to assess the effect of the ADMIT interventions on coagulation...
- Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp ratM B Elam
Department of Veterans Affairs Medical Center, Memphis, TN, USA
J Lipid Res 42:2039-48. 2001..Greater secretion of VLDL in the cp/cp rat in part results from higher endogenous fatty acid synthesis, which in turn may occur in response to increased expression of the lipogenic enzyme regulator SREBP-1c...